Free Trial
ASX:BIT

Biotron (BIT) Stock Price, News & Analysis

Biotron logo

About Biotron Stock (ASX:BIT)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.03 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
5.08%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. The company was incorporated in 1999 and is based in Sydney, Australia.

Receive BIT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotron and its competitors with MarketBeat's FREE daily newsletter.

BIT Stock News Headlines

Biotron Limited Issues New Shares on ASX
Biotron Limited Updates Disclosure Policy Amid ASX Concerns
What Comes Next Could Be a Once-in-a-Lifetime Opportunity
A wave of technological and financial transformation is reshaping the investment landscape. For those who understand the shifts ahead, this could be the foundation for long-term wealth creation. In this exclusive briefing, I'll show you exactly how to prepare for the challenges and opportunities ahead. You'll learn actionable strategies to protect your portfolio and position yourself for growth in the months and years to come.
Biotron Limited Announces New Securities Quotation on ASX
Biotron’s Mixed Trial Results and Future Prospects
Biotron Limited Options Expiry Approaches
Biotron Limited Releases 2024 Annual Report and AGM Notice
See More Headlines

BIT Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Biotron investors own include TPG Co. Limited (TPM.AX) (TPM), Gemfields Group (GEM), Northern Star Resources (NST), Nokia Oyj (NOK), Mesoblast (MESO), MARA (MARA) and FYI Resources (FYI).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Net Income
$-3,440,000.00
Net Margins
-208.89%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.65 million

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
-0.61
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

This page (ASX:BIT) was last updated on 11/22/2024 by MarketBeat.com Staff
From Our Partners